These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 20588274)
1. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Franceschi S; Lise M; Clifford GM; Rickenbach M; Levi F; Maspoli M; Bouchardy C; Dehler S; Jundt G; Ess S; Bordoni A; Konzelmann I; Frick H; Dal Maso L; Elzi L; Furrer H; Calmy A; Cavassini M; Ledergerber B; Keiser O; Br J Cancer; 2010 Jul; 103(3):416-22. PubMed ID: 20588274 [TBL] [Abstract][Full Text] [Related]
2. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S; J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006 [TBL] [Abstract][Full Text] [Related]
3. Trends in Malignancies among Korean Patients Infected with Human Immunodeficiency Virus in the Highly Active Antiretroviral Therapy Era. Lee S; Lee SH; Lee JE; Kang JS; Lee SG; Chung JS; Kwak IS J Korean Med Sci; 2017 Sep; 32(9):1445-1450. PubMed ID: 28776339 [TBL] [Abstract][Full Text] [Related]
4. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy. Mukhtar F; Ilozumba M; Utuama O; Cimenler O JAMA Oncol; 2018 Jan; 4(1):48-53. PubMed ID: 28837714 [TBL] [Abstract][Full Text] [Related]
5. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic. Ives NJ; Gazzard BG; Easterbrook PJ J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320 [TBL] [Abstract][Full Text] [Related]
6. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study. Hernández-Ramírez RU; Shiels MS; Dubrow R; Engels EA Lancet HIV; 2017 Nov; 4(11):e495-e504. PubMed ID: 28803888 [TBL] [Abstract][Full Text] [Related]
7. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. International Collaboration on HIV and Cancer J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759 [TBL] [Abstract][Full Text] [Related]
8. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta. Gingues S; Gill MJ HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981 [TBL] [Abstract][Full Text] [Related]
9. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review. Cobucci RN; Lima PH; de Souza PC; Costa VV; Cornetta Mda C; Fernandes JV; Gonçalves AK J Infect Public Health; 2015; 8(1):1-10. PubMed ID: 25294086 [TBL] [Abstract][Full Text] [Related]
10. Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007. Seaberg EC; Wiley D; Martínez-Maza O; Chmiel JS; Kingsley L; Tang Y; Margolick JB; Jacobson LP; Cancer; 2010 Dec; 116(23):5507-16. PubMed ID: 20672354 [TBL] [Abstract][Full Text] [Related]
11. AIDS malignancies in the era of highly active antiretroviral therapy. Gates AE; Kaplan LD Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534 [TBL] [Abstract][Full Text] [Related]
12. Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. Polesel J; Clifford GM; Rickenbach M; Dal Maso L; Battegay M; Bouchardy C; Furrer H; Hasse B; Levi F; Probst-Hensch NM; Schmid P; Franceschi S; AIDS; 2008 Jan; 22(2):301-6. PubMed ID: 18097233 [TBL] [Abstract][Full Text] [Related]
13. The pattern of secondary cancers in patients with Kaposi sarcoma in the United States. Kumar V; Garg M; Chaudhary N; Soni P; Floudas CS; Nwanyanwu C; Chandra A Cancer Causes Control; 2017 Oct; 28(10):1065-1074. PubMed ID: 28900786 [TBL] [Abstract][Full Text] [Related]
14. Cancer risk in people infected with human immunodeficiency virus in the United States. Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450 [TBL] [Abstract][Full Text] [Related]
15. Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. Franceschi S; Maso LD; Rickenbach M; Polesel J; Hirschel B; Cavassini M; Bordoni A; Elzi L; Ess S; Jundt G; Mueller N; Clifford GM Br J Cancer; 2008 Sep; 99(5):800-4. PubMed ID: 18665172 [TBL] [Abstract][Full Text] [Related]
16. Trends in the incidence of AIDS-defining and non-AIDS-defining cancers in people living with AIDS: a population-based study from São Paulo, Brazil. Tanaka LF; Latorre MDRD; Gutierrez EB; Heumann C; Herbinger KH; Froeschl G Int J STD AIDS; 2017 Oct; 28(12):1190-1198. PubMed ID: 28178892 [TBL] [Abstract][Full Text] [Related]
17. Long-term cancer risk among people diagnosed with AIDS during childhood. Simard EP; Shiels MS; Bhatia K; Engels EA Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):148-54. PubMed ID: 22068287 [TBL] [Abstract][Full Text] [Related]
18. AIDS-related cancers in the era of highly active antiretroviral therapy. Biggar RJ Oncology (Williston Park); 2001 Apr; 15(4):439-48; discussion 448-9. PubMed ID: 11346932 [TBL] [Abstract][Full Text] [Related]
19. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Dal Maso L; Polesel J; Serraino D; Lise M; Piselli P; Falcini F; Russo A; Intrieri T; Vercelli M; Zambon P; Tagliabue G; Zanetti R; Federico M; Limina RM; Mangone L; De Lisi V; Stracci F; Ferretti S; Piffer S; Budroni M; Donato A; Giacomin A; Bellù F; Fusco M; Madeddu A; Vitarelli S; Tessandori R; Tumino R; Suligoi B; Franceschi S; Br J Cancer; 2009 Mar; 100(5):840-7. PubMed ID: 19223894 [TBL] [Abstract][Full Text] [Related]